Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Low-dose intravenous ketamine for prevention of post-dural puncture headache after spinal anesthesia in elective cesarean section
IRCT20190202042589N1Phase 3Completed
- Sponsor
- Vice Chancellor for Research, Birjand University of Medical Sciences
- Start
- Feb 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in post-dural puncture headache (PDPH) comparing Intravenous ketamine with Placebo normal saline (2 arms). Primary endpoints: Incidence of headache, Severity of headache and 4 more. Started Feb 2019; status: completed.
02
Drugs
ketamine
03
Conditions
post-dural puncture headache (PDPH)
Beyond the preview
Go deeper on IRCT20190202042589N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20190202042589N1.